Elanco Animal Health (ELAN) EBT Margin Growth (1y) (2018 - 2026)
Elanco Animal Health (ELAN) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.07 Bn | 7.41 Bn | 397.90 Mn | -2,721.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 208.00 |
| Mar 31, 2026 | 132.00 |
| Dec 31, 2025 | -1,764.00 |
| Sep 30, 2025 | -5,867.00 |
| Jun 30, 2025 | 472.00 |
| Mar 31, 2025 | 403.00 |
| Dec 31, 2024 | 727.00 |
| Sep 30, 2024 | 15,699.00 |
| Jun 30, 2024 | 477.00 |
| Mar 31, 2024 | -760.00 |
| Dec 31, 2023 | -323.00 |
| Sep 30, 2023 | -9,843.00 |
| Jun 30, 2023 | -628.00 |
| Mar 31, 2023 | 247.00 |
| Dec 31, 2022 | 176.00 |
| Sep 30, 2022 | 721.00 |
| Jun 30, 2022 | 1,782.00 |
| Mar 31, 2022 | 1,231.00 |
| Dec 31, 2021 | 1,712.00 |
| Sep 30, 2021 | 1,199.00 |